Your browser doesn't support javascript.
loading
Combined chemotherapy and pembrolizumab salvages multi-chemotherapy agent and avelumab resistant choriocarcinoma: A case report.
Lehmann, M; Hosa, H; Bartl, T; Tsibulak, I; Polterauer, S; Pötsch, N; Seckl, M J; Marth, C.
Afiliación
  • Lehmann M; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.
  • Hosa H; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.
  • Bartl T; Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria.
  • Tsibulak I; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.
  • Polterauer S; Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria.
  • Pötsch N; Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
  • Seckl MJ; Deptartment of Medical Oncology, Charing Cross Hospital Campus of Imperial College London, London, United Kingdom.
  • Marth C; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.
Gynecol Oncol Rep ; 49: 101259, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37636493

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Gynecol Oncol Rep Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Gynecol Oncol Rep Año: 2023 Tipo del documento: Article